School of Medicine
Showing 5,121-5,140 of 13,034 Results
-
David Jimenez-Morales
Sr Research Engineer, Medicine - Med/Cardiovascular Medicine
Current Role at StanfordBioinformatics Lead & Senior Research Scientist Department of Medicine, Division of Cardiovascular Medicine
At Stanford, Dr. Jimenez-Morales owns and leads organization-wide data initiatives, most notably for the Molecular Transducers of Physical Activity Consortium (MoTrPAC) and COVID-omics projects. He coordinates a multidisciplinary team of analysts and researchers, overseeing the data engineering and analysis for complex multi-omics, multi-tissue in-vivo, and clinical studies.
A key aspect of his role involves developing innovative, scalable computational infrastructure from the ground up. This includes engineering comprehensive data injection and quality control systems, and implementing FAIR data science principles. He also serves as a mentor to staff, postdocs, and graduate students, cultivating a collaborative and highly productive research environment. -
Yingying Jin
Postdoctoral Scholar, Human Gene Therapy
BioYingying is a postdoctoral researcher at Kay Lab. She completed her PhD at Peking Union Medical College in China in 2024, under the supervision of Prof. De-Pei Liu. Her research focused on gene editing and ssDNA-protein interactions. During her PhD, she developed an innovative strategy to enhance HDR efficiency of ssDNA donors by incorporating HDR-boosting modules. In 2025, she joined Kay Lab, where her current work involves improving exogenous gene expression delivered by AAV through engineering the AAV genome.
-
Booil Jo
Professor of Psychiatry and Behavioral Sciences (Interdisciplinary Brain Science Research)
Current Research and Scholarly InterestsLatent Variable Modeling, Causal Inference, Longitudinal Data Analysis, Missing Data Analysis, Mixture and Growth Mixture Modeling, Prevention Science Methodology.
-
Jeyun Jo
Postdoctoral Scholar, Pathology
BioDr. Jeyun Jo received his Pharm.D. from Pusan National University in 2016 and his Ph.D. in pharmacy at the same institution in 2021. His thesis studies focused on the first total synthesis of anmindenol A and optimization of 2-anilinopyrimidine-based selective inhibitors against triple-negative breast cancer cells. He then worked for one year as a senior research scientist at Chong Kun Dang, a leading pharmaceutical company in Korea, where he developed large-sacale synthetic processes for engineered peptides. In May 2022, he joined the Bogyo lab at Stanford University as a postdoctoral fellow. His current research focuses on developing highly selective inhibitors and activity-based probes targeting specific serine hydrolases in pathogenic bacteria and cancer.
